60 Degrees Pharmaceuticals, Inc. Common Stock
$0.85
-$0.05 (-5.80%)
$0.84Day Range$0.90
Key Statistics
Market Cap
$2.98M
Shares Outstanding
3.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 12, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$0.90
Day High
$0.90
Day Low
$0.84
Volume
61.9K
VWAP
$0.87
Prev Close
$0.90
Transactions
--
Acc. Volume
--
About 60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
PHARMACEUTICAL PREPARATIONSSIC 28343 employees1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, 20036202-327-5422IPO Jul 12, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001946563
- Composite FIGI
- BBG00NXBJGQ4
- Share Class FIGI
- BBG00NXBJGR3
- Ticker Root
- SXTP
- SIC Code
- 2834
About 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Stock
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) closed the 2026-09-15 session at $0.85, down 5.80% versus the previous close (-0.05). The stock opened at $0.90 and traded between $0.84 and $0.90 during that session. Session trading volume was 62K shares. The volume-weighted average price (VWAP) is $0.87.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
60 Degrees Pharmaceuticals, Inc. Common Stock has a market capitalization of $3.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SXTP is listed on the XNAS exchange. The company employs approximately 3 people. 60 Degrees Pharmaceuticals, Inc. Common Stock is headquartered in WASHINGTON, DC. The recorded listing date is 2023-07-12.
On this page you can find market SXTP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.